OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Target regimen profiles for tuberculosis treatment
Christian Lienhardt, Kelly E. Dooley, Payam Nahid, et al.
Bulletin of the World Health Organization (2024) Vol. 102, Iss. 08, pp. 600-607
Open Access | Times Cited: 10
Christian Lienhardt, Kelly E. Dooley, Payam Nahid, et al.
Bulletin of the World Health Organization (2024) Vol. 102, Iss. 08, pp. 600-607
Open Access | Times Cited: 10
Showing 10 citing articles:
Tuberculosis: An Update for the Clinician
Saskia Janssen, Melissa Murphy, Caryn M. Upton, et al.
Respirology (2025)
Open Access
Saskia Janssen, Melissa Murphy, Caryn M. Upton, et al.
Respirology (2025)
Open Access
A Year in Review on Tuberculosis and Non-tuberculous Mycobacteria Disease: A 2025 Update for Clinicians and Scientists
Christoph Lange, Graham Bothamley, Gunar GĂĽnther, et al.
Pathogens and Immunity (2025) Vol. 10, Iss. 2, pp. 1-45
Open Access
Christoph Lange, Graham Bothamley, Gunar GĂĽnther, et al.
Pathogens and Immunity (2025) Vol. 10, Iss. 2, pp. 1-45
Open Access
panTB-HM: a clinical trial of a pan-TB regimen targeting both host and microbe
Don Mudzengi, S. Mashatole, Xiang Qu, et al.
Research Square (Research Square) (2025)
Closed Access
Don Mudzengi, S. Mashatole, Xiang Qu, et al.
Research Square (Research Square) (2025)
Closed Access
Potential of Pan-Tuberculosis Treatment to Drive Emergence of Novel Resistance
Christopher Finn McQuaid, Theresa Ryckman, Nicolas A. Menzies, et al.
Emerging infectious diseases (2024) Vol. 30, Iss. 8
Open Access | Times Cited: 3
Christopher Finn McQuaid, Theresa Ryckman, Nicolas A. Menzies, et al.
Emerging infectious diseases (2024) Vol. 30, Iss. 8
Open Access | Times Cited: 3
Research on the treatment of rifampin-susceptible tuberculosis—Time for a new approach
William J. Burman, Oxana Rucsineanu, C. Robert Horsburgh, et al.
PLoS Medicine (2024) Vol. 21, Iss. 7, pp. e1004438-e1004438
Open Access | Times Cited: 3
William J. Burman, Oxana Rucsineanu, C. Robert Horsburgh, et al.
PLoS Medicine (2024) Vol. 21, Iss. 7, pp. e1004438-e1004438
Open Access | Times Cited: 3
Projected health and economic effects of a pan-tuberculosis treatment regimen: a modelling study
Theresa Ryckman, Christopher Finn McQuaid, Ted Cohen, et al.
The Lancet Global Health (2024) Vol. 12, Iss. 10, pp. e1629-e1637
Open Access | Times Cited: 3
Theresa Ryckman, Christopher Finn McQuaid, Ted Cohen, et al.
The Lancet Global Health (2024) Vol. 12, Iss. 10, pp. e1629-e1637
Open Access | Times Cited: 3
Accelerating TB regimen development: introducing FAST-TB
Tara Devezin, C. Chisholm, F. Jones, et al.
Deleted Journal (2024) Vol. 1, Iss. 11, pp. 483-485
Open Access
Tara Devezin, C. Chisholm, F. Jones, et al.
Deleted Journal (2024) Vol. 1, Iss. 11, pp. 483-485
Open Access
Blood RNA signatures for 8-week sputum tuberculosis culture sterilisation: how close are we?
Win Pa Pa Thu, Fei Kean Loh, Ong C
European Respiratory Journal (2024) Vol. 64, Iss. 5, pp. 2401669-2401669
Closed Access
Win Pa Pa Thu, Fei Kean Loh, Ong C
European Respiratory Journal (2024) Vol. 64, Iss. 5, pp. 2401669-2401669
Closed Access
Tiled Amplicon Sequencing Enables Culture-free Whole-Genome Sequencing of Pathogenic Bacteria From Clinical Specimens
Chaney C. Kalinich, Freddy L. Gonzalez, Alice Osmaston, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Chaney C. Kalinich, Freddy L. Gonzalez, Alice Osmaston, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
